Integral Health Asset Management »

Upstream Bio shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 575k 18.81

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
Decheng Capital
BlackRock
Enavate Sciences GP
Vanguard Group
Bain Capital Life Sciences Investors
TCG Crossover Management
Altshuler Shaham
Omega Fund Management
VR Adviser
Wellington Management Company
State Street Corporation
Samsara BioCapital
Marshall Wace

View all funds holding Upstream Bio